/
/
/

Lyka Labs Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Mar 2017Dec 2016Sep 2016Jun 2016Mar 2016Dec 2015Sep 2015Jun 2015Mar 2015Dec 2014Sep 2014Jun 2014Mar 2014Dec 2013Sep 2013Jun 2013Mar 2013Dec 2012Sep 2012Jun 2012Mar 2012Dec 2011Sep 2011
₹42 Cr₹28 Cr₹31 Cr₹37 Cr₹33 Cr₹33 Cr₹34 Cr₹41 Cr₹30 Cr₹28 Cr₹33 Cr₹28 Cr₹23 Cr₹22 Cr₹18 Cr₹26 Cr₹27 Cr₹35 Cr₹36 Cr₹74 Cr₹49 Cr₹24 Cr₹27 Cr₹17 Cr₹18 Cr₹15 Cr₹18 Cr₹14 Cr₹14 Cr₹24 Cr₹18 Cr₹15 Cr₹32 Cr₹32 Cr₹33 Cr₹21 Cr₹36 Cr₹31 Cr₹35 Cr₹48 Cr₹41 Cr₹48 Cr₹39 Cr₹19 Cr₹31 Cr₹18 Cr₹26 Cr₹25 Cr₹33 Cr₹29 Cr₹34 Cr₹32 Cr₹29 Cr₹21 Cr₹27 Cr
₹42 L₹61 L₹1 Cr₹1 Cr₹63 L₹82 L₹83 L₹3 L₹56 L₹29 L₹54 L₹25 L₹38 L₹43 L₹1 Cr₹1 Cr₹72 L₹53 L₹41 L₹69 L₹47 L₹55 L₹29 L₹36 L₹36 L₹1 Cr₹93 L₹35 L₹23 L₹72 L₹48 L₹42 L₹2 Cr₹7 L₹30 L₹22 L₹10 L₹82 L₹36 L₹28 L₹54 L₹1 Cr₹46 L₹86 L₹46 L₹3 Cr₹89 L₹1 Cr₹1 Cr₹14 L₹1 Cr₹63 L₹1 Cr₹82 L₹36 L
₹43 Cr₹29 Cr₹32 Cr₹38 Cr₹34 Cr₹34 Cr₹35 Cr₹41 Cr₹31 Cr₹28 Cr₹33 Cr₹28 Cr₹23 Cr₹23 Cr₹19 Cr₹27 Cr₹28 Cr₹36 Cr₹36 Cr₹75 Cr₹50 Cr₹25 Cr₹27 Cr₹18 Cr₹18 Cr₹16 Cr₹19 Cr₹14 Cr₹15 Cr₹25 Cr₹18 Cr₹16 Cr₹34 Cr₹32 Cr₹33 Cr₹21 Cr₹36 Cr₹32 Cr₹36 Cr₹48 Cr₹41 Cr₹49 Cr₹40 Cr₹19 Cr₹31 Cr₹21 Cr₹27 Cr₹26 Cr₹34 Cr₹29 Cr₹35 Cr₹32 Cr₹30 Cr₹22 Cr₹28 Cr
₹40 Cr₹37 Cr₹31 Cr₹41 Cr₹31 Cr₹31 Cr₹30 Cr₹38 Cr₹28 Cr₹29 Cr₹29 Cr₹27 Cr₹24 Cr₹22 Cr₹19 Cr₹24 Cr₹25 Cr₹32 Cr₹25 Cr₹32 Cr₹22 Cr₹20 Cr₹23 Cr₹16 Cr₹16 Cr₹17 Cr₹22 Cr₹16 Cr₹17 Cr₹26 Cr₹16 Cr₹22 Cr₹28 Cr₹28 Cr₹28 Cr₹21 Cr₹34 Cr₹30 Cr₹32 Cr₹40 Cr₹37 Cr₹42 Cr₹35 Cr₹22 Cr₹33 Cr₹23 Cr₹24 Cr₹23 Cr₹39 Cr₹25 Cr₹29 Cr₹26 Cr₹27 Cr₹22 Cr₹27 Cr
₹5 Cr-₹6 Cr₹3 Cr-₹1 Cr₹4 Cr₹5 Cr₹6 Cr₹5 Cr₹4 Cr₹2 Cr₹7 Cr₹4 Cr₹3 Cr₹4 Cr₹3 Cr₹6 Cr₹7 Cr₹13 Cr₹13 Cr₹46 Cr₹30 Cr₹7 Cr₹6 Cr₹4 Cr₹4 Cr₹1 Cr-₹1 Cr-₹29 L-₹72 L-₹27 L₹4 Cr-₹4 Cr₹7 Cr₹7 Cr₹8 Cr₹3 Cr₹4 Cr₹4 Cr₹6 Cr₹11 Cr₹6 Cr₹10 Cr₹8 Cr-₹2 Cr-₹15 L-₹30,000₹5 Cr₹5 Cr₹3 Cr₹5 Cr₹8 Cr₹7 Cr₹4 Cr₹1 Cr₹3 Cr
₹1 Cr₹70 L₹82 L₹79 L₹85 L₹47 L₹61 L₹54 L₹65 L₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹5 Cr₹6 Cr₹7 Cr₹6 Cr₹7 Cr₹7 Cr₹6 Cr₹6 Cr₹11 Cr₹2 Cr₹2 Cr₹3 Cr₹1 Cr₹2 Cr₹4 Cr₹5 Cr₹4 Cr₹4 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹6 Cr₹6 Cr₹5 Cr₹6 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹6 Cr₹6 Cr₹5 Cr
₹2 Cr-₹9 Cr-₹16 L-₹4 Cr₹1 Cr₹3 Cr₹4 Cr₹3 Cr₹2 Cr-₹2 Cr₹3 Cr-₹79 L-₹2 Cr-₹3 Cr-₹10 Cr-₹64 L₹76 L-₹2 Cr₹7 Cr₹33 Cr₹21 Cr-₹3 Cr-₹2 Cr-₹5 Cr-₹4 Cr-₹13 Cr-₹41 Cr-₹4 Cr-₹4 Cr-₹2 Cr-₹2 Cr-₹8 Cr-₹30 L-₹2 Cr₹84 L-₹4 Cr-₹14 Cr-₹3 Cr₹18 Cr₹3 Cr-₹2 Cr-₹5 Cr₹7 Cr-₹8 Cr-₹16 Cr-₹10 Cr-₹3 Cr-₹2 Cr-₹12 Cr₹9 Cr₹1 Cr₹2 Cr₹9 Cr-₹3 Cr-₹4 Cr
₹2 Cr-₹8 Cr-₹15 L-₹3 Cr₹100 L₹2 Cr₹3 Cr₹2 Cr₹1 Cr-₹2 Cr₹2 Cr-₹62 L-₹2 Cr-₹3 Cr-₹11 Cr-₹34 L₹71 L-₹15 Cr₹6 Cr₹28 Cr₹19 Cr₹2 Cr-₹2 Cr-₹6 Cr-₹4 Cr-₹14 Cr-₹41 Cr-₹4 Cr-₹4 Cr₹8 Cr-₹2 Cr-₹7 Cr₹2 L-₹3 Cr₹98 L-₹4 Cr-₹17 Cr₹14 L₹18 Cr₹3 Cr-₹2 Cr-₹5 Cr₹7 Cr-₹9 Cr₹19 Cr-₹10 Cr-₹3 Cr-₹2 Cr-₹12 Cr₹9 Cr₹1 Cr₹2 Cr₹9 Cr-₹3 Cr-₹4 Cr

Share Price Live Stats

Open (₹)78.36
Volume (₹)9,011.00
High (₹)78.36
Upper Circuit78.36
Low (₹)78.36
Lower Circuit75.30
Prev Close76.83
52W High (₹)101.99
Price78.36
52W Low (₹)44.10

Share Market Cap & Key Ratios Overview

M.Cap (₹)280.26 Cr
Div. Yield (%)0.00
PE Ratio0.00
Debt to Equity0.53
Price to Book1.74
Book Value25.76
EPS (TTM)-2.46
Face Value10.00
ROE (%)-10.64

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LYKALABS-BENSE
LTP
1W Low
1W High
Market cap (₹)
1904.8-15.2 (-0.79%)
1902
1984.80
4,56,833Cr
9187.5-51.5 (-0.56%)
9087
9467
2,45,426Cr
4901.5-148.5 (-2.94%)
4886.50
5066
1,87,320Cr
1133.6-57.4 (-4.82%)
1125.10
1187
1,13,217Cr
1389.7-33.8 (-2.37%)
1376.70
1426.10
1,12,212Cr
1852.8-85.7 (-4.42%)
1811.70
1949
1,01,155Cr
2126.3-45.2 (-2.08%)
2118.10
2192
97,626Cr
2351.8-31.1 (-1.31%)
2341.20
2419.20
96,859Cr
1163.8-14.2 (-1.21%)
1154.40
1179.90
96,406Cr
1654.9+9.6 (0.58%)
1622.60
1717
93,614Cr
78.36+3.56 (4.76%)
73
78.36
280Cr

Key Highlights of Lyka Labs Ltd’s P&L

In 2026-03-31, Lyka Labs Ltd reported total revenue of ₹131.94Cr, compared with ₹140.73Cr in 2025-03-31, reflecting Lyka Labs Ltd turnover.

Depreciation was ₹8.46Cr and finance costs were ₹3.33Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹-₹11.78Cr in 2026-03-31 as compared to ₹11.12Cr in 2025-03-31.

Net Profit (PAT) was ₹-₹10.03Cr in 2026-03-31 compared with ₹8.01Cr in 2025-03-31.

Earnings per share (EPS) were ₹-2.81 in 2026-03-31, compared with ₹2.24 in 2025-03-31.